{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:05:09Z","timestamp":1785305109859,"version":"3.55.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pre-eclampsia remains a leading cause of maternal morbidity and mortality worldwide. However, evidence regarding the implementation of risk management strategies in low- and middle-income settings remains limited. This exploratory survey assessed knowledge, clinical practices, guideline implementation, and perceived barriers related to pre-eclampsia risk management among obstetricians in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A web-based exploratory cross-sectional survey using convenience and snowball sampling was conducted among obstetricians in China. An anonymous 38-item questionnaire was developed based on two-step pre-eclampsia risk management strategies and distributed through academic networks and professional groups. Descriptive analyses were performed using frequencies and proportions for categorical variables and medians with interquartile ranges for continuous variables. Exploratory subgroup analyses were conducted by participant characteristics. Guideline adherence was assessed against key recommendations from four guidelines used in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 307 obstetricians, 91.9% reported performing pre-eclampsia risk prediction, primarily based on medical history, obstetric history, and current pregnancy factors. However, considerable variation existed in assessment timing and risk classification approaches. Although the FMF competing-risk model was recognized as important, only 61.6% had heard of the model and 36.5% reported clinical use. Limited biomarker availability and lack of automated calculation tools were the main barriers. Low-dose aspirin prophylaxis was widely reported, with 90.9% prescribing aspirin for women at moderate or high risk. The most common regimen was 100 mg once daily, initiated at 12 weeks and discontinued at 36 weeks. Only 56.0% reported initiating aspirin before 16 weeks, and 1.0% reported continuation until delivery, indicating substantial variation in aspirin management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This exploratory survey suggests that obstetricians in China have incorporated some components of pre-eclampsia risk management into clinical practice, but substantial variability remains in guideline implementation. Limited adoption of standardized risk assessment tools and inconsistent aspirin prophylaxis strategies highlight potential areas for improvement. Enhancing implementation support and improving access to evidence-based tools may facilitate more consistent pre-eclampsia prevention practices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1890291","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:57:47Z","timestamp":1785304667000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge, practice patterns, and guideline implementation for pre-eclampsia risk management among obstetricians in China: an exploratory cross-sectional survey"],"prefix":"10.3389","volume":"14","author":[{"given":"Sha","family":"Diao","sequence":"first","affiliation":[{"name":"Clinical Epidemiology and Evidence-Based Medicine Center, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Department of Pharmacy\/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Children's Medicine Key Laboratory of Sichuan Province","place":["Chengdu, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiu","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pharmacy\/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Children's Medicine Key Laboratory of Sichuan Province","place":["Chengdu, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[{"name":"West China School of Pharmacy, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy\/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Children's Medicine Key Laboratory of Sichuan Province","place":["Chengdu, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy\/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Children's Medicine Key Laboratory of Sichuan Province","place":["Chengdu, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy\/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Children's Medicine Key Laboratory of Sichuan Province","place":["Chengdu, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy\/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Children's Medicine Key Laboratory of Sichuan Province","place":["Chengdu, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education","place":["Chengdu, China"]},{"name":"West China Biomedical Big Data Center, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education","place":["Chengdu, China"]},{"name":"Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy\/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Children's Medicine Key Laboratory of Sichuan Province","place":["Chengdu, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education","place":["Chengdu, China"]},{"name":"West China Biomedical Big Data Center, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee","year":"2022","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1097\/AOG.0000000000005576","article-title":"Biomarker prediction of preeclampsia with severe features","volume":"143","year":"2024","journal-title":"Obstet Gynecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/ehjcvp\/pvae012","article-title":"Hypertension in pregnancy-what's new in the 2023 ESH guidelines for the management of arterial hypertension","volume":"10","author":"C\u00edfkov\u00e1","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/jama.2023.16991","article-title":"Screening for hypertensive disorders of pregnancy: US preventive services task force final recommendation statement","volume":"330","author":"US Preventive Services Task","year":"2023","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12892","article-title":"The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet."},{"key":"B7","volume-title":"WHO Recommendations on Antiplatelet Agents for the Prevention of Pre-eclampsia [Internet]","year":"2021"},{"key":"B8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3760\/cma.j.cn112141-20210506-00251","article-title":"Chinese expert consensus on pregnancy blood pressure management (2021)","volume":"56","year":"2021","journal-title":"Chin J Obstet Gynecol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/1471-0528.17320","article-title":"Risk factors for pre-eclampsia in clinical practice guidelines: comparison with the evidence","volume":"131","author":"Elawad","year":"2024","journal-title":"BJOG."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/1471-0528.14029","article-title":"The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review","volume":"123","author":"Al-Rubaie","year":"2016","journal-title":"BJOG."},{"key":"B11","doi-asserted-by":"publisher","first-page":"101564","DOI":"10.1016\/j.ajogmf.2025.101620","article-title":"Aspirin dose for preeclampsia prophylaxis: an argument for 162-mg dosing","volume":"7","author":"Jones Pullins","year":"2024","journal-title":"Am J Obstet Gynecol MFM."},{"key":"B12","doi-asserted-by":"publisher","first-page":"101568","DOI":"10.1016\/j.ajogmf.2024.101568","article-title":"Aspirin dosage for preeclampsia prophylaxis: an argument for 81 mg dosing","volume":"7","author":"Balhotra","year":"2025","journal-title":"Am J Obstet Gynecol MFM."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1080\/14767058.2019.1566311","article-title":"Obstetricians' knowledge and practices regarding the management of preeclampsia","volume":"33","author":"Snead","year":"2020","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1186\/s12913-022-08892-5","article-title":"Knowledge and skills of pre-eclampsia management among healthcare providers working in antenatal clinics in Zanzibar","volume":"22","author":"Seif","year":"2022","journal-title":"BMC Health Serv Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1120","DOI":"10.1055\/a-1990-2728","article-title":"Physician's knowledge and practices surrounding low-dose aspirin for preeclampsia risk reduction","volume":"41","author":"Martinez-King","year":"2024","journal-title":"Am J Perinatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"23779608231193745","DOI":"10.1177\/23779608231193745","article-title":"Knowledge and attitude of healthcare providers on managing pre-eclampsia and eclampsia during antenatal care in Mwanza Region-Tanzania","volume":"9","author":"Pallangyo","year":"2023","journal-title":"SAGE Open Nurs."},{"key":"B17","doi-asserted-by":"publisher","first-page":"101145","DOI":"10.1016\/j.preghy.2024.101145","article-title":"Pre-eclampsia and future cardiovascular disease risk: assessing British clinicians' knowledge and practice","volume":"37","author":"Jones","year":"2024","journal-title":"Pregnancy Hypertens."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES)","volume":"6","author":"Eysenbach","year":"2004","journal-title":"J Med Internet Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajog.2019.11.1247","article-title":"The competing risk approach for prediction of preeclampsia","volume":"223","author":"Wright","year":"2020","journal-title":"Am J Obstet Gynecol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"i","DOI":"10.47263\/JASEM.4(2)01","article-title":"Sample size for survey research: review and recommendations","volume":"4","author":"Memon","year":"2020","journal-title":"J Appl Struct Equ Model."},{"key":"B23","doi-asserted-by":"publisher","first-page":"089033442090685","DOI":"10.1177\/0890334420906850","article-title":"Sampling methods","volume":"36","author":"Berndt","year":"2020","journal-title":"J Hum Lact."},{"key":"B24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3760\/cma.j.cn112141-20200114-00039","article-title":"Guidelines for diagnosis and treatment of hypertensive disorders in pregnancy (2020)","volume":"55","year":"2020","journal-title":"Chin J Obstet Gynecol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3760\/cma.j.cn112148-20191024-00652","article-title":"Expert consensus on blood pressure management of hypertensive diseases in pregnancy (2019)","volume":"48","year":"2020","journal-title":"Chin J Cardiol."},{"key":"B26","first-page":"128","article-title":"Expert consensus on scientific prevention and control of preeclampsia","volume":"12","author":"Wang","year":"2022","journal-title":"Front Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12884-025-08625-6","article-title":"Inconsistencies in recommendations for the preventive management of pre-eclampsia and quality assessment of international guidelines: a systematic review","volume":"26","author":"Diao","year":"2026","journal-title":"BMC Pregnancy Childbirth."},{"key":"B28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Primers."},{"key":"B29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/uog.23645","article-title":"Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China","volume":"58","author":"Hu","year":"2021","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.preghy.2022.11.001","article-title":"Health care workers and key policy informants' knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women","volume":"30","author":"Ngwira","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"B31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0002-9378(85)80223-4","article-title":"Preeclampsia: an imbalance in placental prostacyclin and thromboxane production","volume":"152","author":"Walsh","year":"1985","journal-title":"Am J Obstet Gynecol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.plefa.2003.04.010","article-title":"Eicosanoids in preeclampsia","volume":"70","author":"Walsh","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"key":"B33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.placenta.2017.05.004","article-title":"Increased placental phospholipase A2 gene expression and free F2-isoprostane levels in response to oxidative stress in preeclampsia","volume":"55","author":"Brien","year":"2017","journal-title":"Placenta."},{"key":"B34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jama.282.4.356","article-title":"2nd, Clemens JD, et al. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study","volume":"282","author":"Mills","year":"1999","journal-title":"JAMA."},{"key":"B35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2125.2011.03943.x","article-title":"Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy","volume":"72","author":"Warner","year":"2011","journal-title":"Br J Clin Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/j.0001-6349.2004.00396.x","article-title":"Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders","volume":"83","author":"Vainio","year":"2004","journal-title":"Acta Obstet Gynecol Scand."},{"key":"B37","doi-asserted-by":"publisher","first-page":"385.e1","DOI":"10.1016\/j.ajog.2019.01.222","article-title":"Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin","volume":"220","author":"Finneran","year":"2019"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1210\/jc.2009-2392","article-title":"Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus","volume":"95","author":"Ertugrul","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/bmj.328.7438.477","article-title":"Aspirin resistance","volume":"328","author":"Hankey","year":"2004","journal-title":"BMJ."},{"key":"B40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5114\/fn.2021.109434","article-title":"Biochemical aspirin resistance in acute stroke patients and its association with clinical factors: a prospective pilot study","volume":"59","author":"Morton","year":"2021","journal-title":"Folia Neuropathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s40265-020-01413-w","article-title":"A narrative review of aspirin resistance in VTE prophylaxis for orthopaedic surgery","volume":"80","author":"van Oosterom","year":"2020","journal-title":"Drugs."},{"key":"B42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ajog.2020.03.005","article-title":"The role of aspirin in prevention of preeclampsia in twin pregnancies: does the dose matter?","volume":"223","author":"Kalafat","year":"2020","journal-title":"Am J Obstet Gynecol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"55.e1","DOI":"10.1016\/j.ajog.2024.12.030","article-title":"Comparison of two aspirin doses for the prophylaxis of pre-eclampsia in twin pregnancy: a multicentre retrospective study with propensity score matching","volume":"233","author":"Zorzato","year":"2025","journal-title":"Am J Obstet Gynecol."},{"key":"B44","volume-title":"WHO Recommendation: Calcium Supplementation During Pregnancy to Reduce the Risk of Pre-eclampsia [Internet]","year":"2023"},{"key":"B45","doi-asserted-by":"publisher","first-page":"S1126","DOI":"10.1016\/j.ajog.2020.11.006","article-title":"Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis","volume":"226","author":"Cruz-Lemini","year":"2022","journal-title":"Am J Obstet Gynecol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.5114\/aoms\/136518","article-title":"Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review","volume":"18","author":"Wu","year":"2021","journal-title":"Arch Med Sci."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1890291\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:57:52Z","timestamp":1785304672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1890291\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":46,"alternative-id":["10.3389\/fpubh.2026.1890291"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1890291","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1890291"}}